Immunotherapeutic approaches of IL-1 neutralization in the tumor microenvironment

Journal of Leukocyte Biology
R N Apte, Elena Voronov

Abstract

IL-1 is a pleiotropic cytokine that controls inflammation, immunity, and hemopoiesis. The major IL-1 agonistic molecules are IL-1α and IL-1β, which bind to IL-1R type I (IL-1R1) and induce similar biologic functions. The IL-1R antagonist (IL-1Ra) is a physiologic inhibitor of IL-1R1 signaling. In the tumor microenvironment, IL-1 is expressed by malignant, stromal, and infiltrating cells and supports tumor invasiveness and progression. We have shown that in the tumor microenvironment, the IL-1 agonistic molecules act different as a result of their local amounts and their compartmentalization within the producing cells. IL-1β is produced mainly by myeloid cells upon inflammatory stimulation and is active as a mature, secreted molecule. The precursor of IL-1α (ProIL-1α) is biologically active; it is constitutively expressed in diverse tissue cells in basal levels, and its expression increases during stress or inflammation. ProIL-1α is mainly located in the cytosol or it is membrane associated. ProIL-1α also translocates into the nucleus and binds to chromatin. ProIL-1α is rarely actively secreted but is released from necrotizing tissues and serves as "alarmin" for initiation of inflammation. In the tumor microenvironment, IL-1β pr...Continue Reading

Citations

Aug 23, 2020·International Journal of Molecular Sciences·Valerio GelfoMattia Lauriola
Jan 27, 2020·Biological Trace Element Research·Yan ZhangHong-Wei Wang
Feb 10, 2021·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Kazuhiko UdagawaMasaya Nakamura
Feb 10, 2021·International Journal of Molecular Sciences·Aldona Kasprzak
Apr 23, 2020·Journal of Autoimmunity·Carlo PerriconeRoberto Gerli
Apr 22, 2021·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Linda BoldrupKarin Nylander
Dec 1, 2020·Pharmacology & Therapeutics·Bingjian WenZhengquan Su
Apr 12, 2021·Cancer Immunology Research·Owen HeathFrances R Balkwill
Dec 21, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Weichao XuXinyu Hao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.